PAF’s role in LPS-induced thrombocytopenia and neutropenia was shown by a study looking at 42 dogs treated with LPS, PAF, or saline, with some animals being pre-treated with TCV-309, a potent PAF antagonist. The gene discussed is PCLAF; the disease is Thrombocytopenia.